New York City, NY -- (SBWIRE) -- 12/16/2013 -- StockMarketIntel.com issues a special report on the following stocks: ALACER GOLD CORP (OTCMKTS:ALIAF), Formcap Corp (OTCMKTS:FRMC), Affymax, Inc. (OTCMKTS:AFFY), Excel Maritime Carriers Ltd (OTCMKTS:EXMCQ)
ALACER GOLD CORP (OTCMKTS:ALIAF) gained 5.65%, trading on 184,905 shares, to end the trade at $2.25. The stock changed hands in a range of $2.14 to $2.29, bringing its market capitalization to about $612.35 million. If we look at its trading history of the past 52 weeks, the share price suffered a low of $1.87 and was moved to the maximum level of $5.40.
Will ALIAF Continue To Move Higher? Find Out Here
Formcap Corp (OTCMKTS:FRMC) added 5.63%, to complete the trading session at $1.50, with a total volume of 200,874 shares. The stock, on average, trades on a volume of 363,334 shares. It floated in a range of $1.44 to $1.52 during the last trading session, with a beta value of -2.97. Its market capitalization now moved to about $138.06 million. In the past 52 weeks, the share price has not declined below $0.01 and above $1.52. FormCap Corp., a development stage company, focuses on the identification and development of oil and gas energy resource properties in North America. The company was formerly known as Gravitas International, Inc. and changed its name to FormCap Corp. in October 2007. FormCap Corp. was founded in 1991 and is based in Reno, Nevada.
Why Should Investors Buy FRMC After The Recent Gain? Just Go Here and Find Out
Affymax, Inc. (OTCMKTS:AFFY) recorded a gain of 4.86% and was in a range of $0.80-$0.85 before closing at $0.850. The stock completed the day with a total volume of 340,294 shares, versus an average volume of 356,300shares. The share price hit its 52-week low of $0.78 and $23.22 was the best price. Affymax, Inc., a biopharmaceutical company, engages in discovering, developing, and delivering therapies that improve the lives of patients with kidney diseases, and other serious and life-threatening illnesses. It offers OMONTYS (peginesatide) injection for the treatment of anemia due to chronic kidney disease in adult patients on dialysis. OMONTYS is a synthetic peptide-based erythropoiesis stimulating agent designed to stimulate production of red blood cells.
What was the Moving Force behind AFFY on Bullish Run? Read This Research Report
Excel Maritime Carriers Ltd (OTCMKTS:EXMCQ) added 4.74%, bringing its market capitalization around $10.72 million. The share price, after opening at $0.11, made a high of $0.12 and hovered above $0.10 to end the day at $0.115. The total number of shares that changed hands during the session was 1.47 million shares, as compared to average trading volume of 448,307 shares. Excel Maritime Carriers Ltd. provides sea borne dry bulk cargo transportation services worldwide. It transports various types of cargo, including iron ore, coal and grain, steel products, fertilizers, cement, bauxite, and sugar and scrap metal. The company owns a fleet of 40 vessels, among which it owns a vessel through a majority interest in joint venture, and together with 7 vessels under bareboat charters, operates 47 vessels comprising 7 Capesize, 14 Kamsarmax, 21 Panamax, 2 Supramax, and 3 Handymax vessels with a total carrying capacity of approximately 4.1 million deadweight tonnage.
For How Long EXMCQ will fight for Profitability? Read This Trend Analysis report
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)